Le Lézard
Classified in: Health, Science and technology
Subject: AWD

ModuleMD Secures Fourth Consecutive Win as G2 High Performers


GRAND BLANC, Mich., May 9, 2024 /PRNewswire/ -- ModuleMD, a leading provider of innovative EHR, Practice Management Software and Revenue Cycle Management (RCM) solutions, proudly announces its fourth consecutive recognition in the G2 High Performers Grid in the EHR software category. The G2 Winter 2024 Grid Report further establishes ModuleMD's reputation as a steadfast and visionary ally for healthcare professionals around the world.

ModuleMD Secures Fourth Consecutive Win as G2 High Performers

As the largest and most trusted software marketplace, G2 guides over 90 million users annually?including employees at all Fortune 500 companies?in making informed software decisions based on genuine peer reviews. With an impressive 94% of reviews on G2 marked as a 4 or 5-star rating for ModuleMD, the consistent recognition as a G2 High Performers Grid Leader underscores the company's dedication to providing exceptional quality, reliability, and customer satisfaction within the healthcare technology landscape. This acknowledgment not only celebrates ModuleMD's achievements, but also solidifies its reputation as a top choice for healthcare professionals seeking superior Healthcare IT software solutions.

Abhinay Penugonda, CEO of ModuleMD, expressed his gratitude, remarking, "We are thrilled to be recognized as a G2 High Performer for the fourth consecutive time. This accomplishment demonstrates our passion for creating industry-leading solutions and ensuring our customers' success. We appreciate the valuable feedback from our loyal customers, which inspires us to continually strive for excellence."

"I was more than happy to share my thoughts on ModuleMD," says Andrea Force, Practice Manager at Allergy Asthma Centers and a loyal ModuleMD customer. "The [ModuleMD] team has always been there for me, and the product just keeps getting better. I'm a firm believer in giving credit where credit is due, and ModuleMD definitely deserves it. When I have a great experience with a company that I truly believe in, I'm always excited to spread the word."

The company's consistent recognition as a G2 High Performers Grid Leader reflects its unwavering commitment to excellence and customer satisfaction. By actively listening to user feedback and embracing industry trends, such as cutting-edge AI technology, ModuleMD has become a resounding voice in the industry, shaping the future of healthcare technology and is a driving force of innovation.

Discover what ModuleMD clients have shared on YouTube

www.modulemd.com 

For user reviews, visit https://www.g2.com/products/modulemd/reviews

ModuleMD Press Contact:

Cheryl Fernandes
[email protected] 

Miranda Moore
[email protected] 

Infographic - https://mma.prnewswire.com/media/2403577/ModuleMD_Infographic.jpg
Logo - https://mma.prnewswire.com/media/2314317/Module_MD_Logo.jpg

 

SOURCE ModuleMD LLC


These press releases may also interest you

at 06:15
The Barbara Ann Karmanos Cancer Institute welcomes Wasif Saif, M.D., MBBS, as the new leader of the Phase 1 Clinical Trials Multidisciplinary Team and co-leader of the Gastrointestinal (GI) and Neuroendocrine Oncology Multidisciplinary Team...

at 06:07
Seed Health will present new clinical data on its flagship innovation, DS-01® Daily Synbiotic, a 24-strain probiotic and prebiotic, at the upcoming 2024 Digestive Disease Week® (DDW) meeting. The presentations will highlight the results from two...

at 06:05
Arrowhead Pharmaceuticals, Inc. today announced that new interim clinical data on ARO-RAGE, an investigational RNAi-based medicine for the treatment of inflammatory lung diseases, such as asthma, were presented at the American Thoracic Society (ATS)...

at 06:00
BrainStorm Cell Therapeutics Inc. , a leading developer of adult stem cell therapeutics for neurodegenerative diseases, will present new biomarker data suggesting that ALS patients may benefit from longer-term treatment with debamestrocel...

at 06:00
Ibex Medical Analytics (Ibex), a global leader in AI-powered cancer diagnostics, and Kameda Medical Center (Kameda), a leading Japanese institute at the pinnacle of healthcare innovation, today announced the publication of a clinical study evaluating...

at 06:00
HaemaLogiX Ltd, a clinical stage biotech developing novel immunotherapies for patients with blood cancers and B-cell diseases, is pleased to announce the appointment of Professor the Hon Greg Hunt, former Australian Federal Minister for Health, to...



News published on and distributed by: